Thomas M. Runge

Thomas M. Runge

Auto-generated profile, based on publicly available information

Thomas M. Runge

Division of Gastroenterology and Hepatology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Gastroenterology Clinics of North America
Verified
Journal Article
Closed access
TRThomas M. Runge
Thomas M. Runge
JAJulian A. Abrams
Julian A. Abrams
NSNicholas J. Shaheen
Nicholas J. Shaheen

1 June 2016 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
SESwathi Eluri
Swathi Eluri
TRThomas M. Runge
Thomas M. Runge
CCCary C. Cotton
Cary C. Cotton
CBCaitlin M. Burk
Caitlin M. Burk
WWW. Asher Wolf
W. Asher Wolf
EDEvan S. Dellon
Evan S. Dellon

3 September 2020 in Endoscopy
Verified
Journal Article
Closed access
PDF file
TRThomas M. Runge
Thomas M. Runge
ACAustin L. Chiang
Austin L. Chiang
TKThomas E. Kowalski
Thomas E. Kowalski
TJTheodore W. James
Theodore W. James
TBTodd H. Baron
Todd H. Baron
MKMouen A. Khashab
Mouen A. Khashab
Background Endoscopic ultrasound-directed transgastric endoscopic retrograde cholangiopancreatography (ERCP; EDGE) is an alternative to enteroscopy- and laparoscopy-assisted ERCP in patients with Roux-en-Y gastric bypass anatomy. Although short-term results are promising, the long-term outcomes are not known. The aims of this study were: (1) to determine the rates of long-term adverse events after EDGE, with a focus on rates of persistent gastrogastric or jejunogastric fistula; (2) to identify predictors of persistent fistula; (3) to assess the outcomes of endoscopic closure when persistent fistula is encountered. Methods This was a multicenter retrospective study involving 13 centers between February 2015 and March 2019. Adverse events were defined according to the ASGE lexicon. Persistent fistula was defined as an upper gastrointestinal series or esophagogastroduodenoscopy showing evidence of fistula. Results 178 patients (mean age 58 years, 79 % women) underwent EDGE. Technical success was achieved in 98 % of cases (175/178), with a mean procedure time of 92 minutes. Periprocedural adverse events occurred in 28 patients (15.7 %; mild 10.1 %, moderate 3.4 %, severe 2.2 %). The four severe adverse events were managed laparoscopically. Persistent fistula was diagnosed in 10 % of those sent for objective testing (9/90). Following identification of a fistula, 5 /9 patients underwent endoscopic closure procedures, which were successful in all cases. Conclusions The EDGE procedure is associated with high clinical success rates and an acceptable risk profile. Persistent fistulas after lumen-apposing stent removal are uncommon, but objective testing is recommended to identify their presence. When persistent fistulas are identified, endoscopic treatment is warranted, and should be successful in closing the fistula.

1 June 2017 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
CCCary C. Cotton
Cary C. Cotton
DEDaniel Erim
Daniel Erim
SESwathi Eluri
Swathi Eluri
SPSarah H. Palmer
Sarah H. Palmer
DGDaniel J. Green
Daniel J. Green
EDEvan S. Dellon
Evan S. Dellon

1 January 2018 in The Journal of Pediatrics
Verified
Journal Article
Closed access
ABA. Sidney Barritt
A. Sidney Barritt
BLBrian Lee
Brian Lee
TRThomas Runge
Thomas Runge
MSMonica Schmidt
Monica Schmidt
RJRavi Jhaveri
Ravi Jhaveri

22 September 2016 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
TRThomas M. Runge
Thomas M. Runge
NSNicholas J. Shaheen
Nicholas J. Shaheen
ZDZorka Djukic
Zorka Djukic
SHSuzanne Hallquist
Suzanne Hallquist
RORoy C. Orlando
Roy C. Orlando